Clinical Trials
The following clinical research trial is enrolling patients at AGICC member and affiliate sites.
Clinical Trial 09CRC02
A Dose Finding and Phase II Study of AZD6244 (Hyd-Sulfate) in Combination with Irinotecan in 2 nd Line Patients with K- ras or B- raf Mutation Positive Advanced or Metastatic Colorectal Cancer.
Protocol SummaryClinical Trial 09CRC01
A Phase II, Open-Label, Multicenter Trial to Assess the Efficacy and Safety of a PARP Inhibitor Alone in Previously Treated Patients with Stage IV, Measurable Colorectal Cancer, Stratified by MSI Status.
Protocol SummaryClinical Trial 09PAN01
A Phase 1b Study of Erlotinib in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Previously Untreated Advanced Pancreatic Cancer.
Protocol Summary | 
